Clinical Trial Update: Effect of Sevelamer Carbonate on Oxidative Stress in Patients With Diabetic Nephropathy [Phase 1]

View source ↗

Summary

Phase 1 trial update assessing whether sevelamer carbonate reduces oxidative stress in patients with diabetic nephropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Diabetic Nephropathy | Phase 1 | Status: COMPLETED